PPA Code Company Name PINFO INFOSYS TECHNOLOGIES
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Download Full Report
CONTENTS 02 Unstoppable Corporate overview We have been persistent 02 Unstoppable in our aim to establishing 04 Chairman’s Message and maintaining market leadership to be able to achieve 06 Vice Chairman’s Message unprecedented growth for our 08 Board of Directors stakeholders. 10 Management Board 12 Key Performance Highlights 14 14 Integrated Report Integrated Report 28 Management Discussion & Analysis Apollo Tyres’ contribution 51 Sustainability Snapshot to social and economic development is critical to create and sustain an enabling environment for investment. This has enabled the Company’s positioning as a credible Statutory Reports stakeholder partner. 84 Board’s Report 95 Annual Report on CSR 28 102 Business Responsibility Report Management 126 Corporate Governance Report Discussion & Analysis Financial Statements 161 Standalone Financial Statements 223 Consolidated Financial Statements UNSTOPPABLE Since inception, we have worked towards establishing ourselves as a leading player in the sale and manufacture of tyres. We have been persistent in our aim to establishing and maintaining market leadership and be able to achieve unprecedented growth for our stakeholders. In FY2018-19 (FY2019), we continued to focus We are unstoppable in establishing our on our key revenue generating regions APMEA leadership across multiple segments. (Asia Pacific, Middle East and Africa, including Our consistently advancing product range coupled India) and Europe. We expanded our presence in with product innovations are enabling us to achieve Americas by added new territories and increasing the same. our value proposition. The APMEA operation continued its focus on consolidating its leadership We are unstoppable in working towards achieving and enhancing share in India through the cutting edge manufacturing capabilities and introduction of best in class and technologically world-class R&D. -
Automobile Industry Updates
India Automobile Industry Updates In this issue: Automobile Industry Updates Effect of Recession GM Files For Bankruptcy Issue No 3 Shifts reduced at Bridgestone factory. May 2009 Press Release Effects of Recession Car Exports Up 42% in May Nashik strike a setback for GM Files for Bankruptcy Mahindra's Xylo It was once an icon for industry. Monday, General Motors became the largest Nashik strike causes production losses of Rs manufacturing company in U.S. history and fourth largest company ever to file for 150 crore to Mahindra's bankruptcy protection. vendors Senior administration officials said the government will provide $30 billion in financing Tata, M&M, Maruti join hands for hybrid models to help the automaker through bankruptcy. Those same officials said the Canadian government would provide $9.5 billion. Global car cos to take Maruti's route JLR to get 'conditional' More support only: UK Govt Shifts reduced at Bridgestone factory Audi aims 55 pc growth this fiscal from India Bridgestone has cut three production shifts at its Salisbury factory as demand slumps Ashok Leyland, Nissan for its truck and trailer tyres. The company told workers this week it needed to reduce venture delayed 6 months inventory levels to match sales, which have fallen during the economic downturn. UK Govt-JLR talks back on Workers will be given other duties during the seven-week hiatus, which will cut truck track and bus tyre production by 20 hours a week. TVS can make, sell original Flame: HC More Tata Motors plans Rs 4,200 cr debenture issue: Crisil Press Release Ford to Make India Export Hub for Small Cars Car Exports Up 42% in May Exports of passenger cars from the country soared 41.64 per cent in May, mainly on Natural rubber imports might double the back of robust performance by Maruti Suzuki, although domestic sales increased by a meager 2.48 per cent. -
Emerging Markets Equity Fund Q3 Portfolio Holdings
Putnam Emerging Markets Equity Fund The fund's portfolio 5/31/21 (Unaudited) COMMON STOCKS (98.8%)(a) Shares Value Airlines (0.9%) Copa Holdings SA Class A (Panama)(NON) 70,700 $5,815,782 5,815,782 Banks (5.7%) HDFC Bank, Ltd. (India)(NON) 889,339 18,568,792 Sberbank of Russia PJSC ADR (Russia) 548,845 9,261,759 TCS Group Holding PLC GDR 144A (Cyprus) 107,200 8,040,000 35,870,551 Capital markets (2.4%) B3 SA - Brasil Bolsa Balcao (Brazil) 3,151,700 10,607,061 Hong Kong Exchanges and Clearing, Ltd. (Hong Kong) 73,200 4,582,015 15,189,076 Chemicals (2.5%) Asian Paints, Ltd. (India) 184,575 7,592,754 LG Chem, Ltd. (South Korea) 11,537 8,471,983 16,064,737 Entertainment (1.7%) Sea, Ltd. ADR (Thailand)(NON) 42,300 10,712,052 10,712,052 Food and staples retail (3.0%) Dino Polska SA (Poland)(NON) 84,264 6,522,925 Wal-Mart de Mexico SAB de CV (Mexico) 3,834,400 12,620,909 19,143,834 Health-care equipment and supplies (1.4%) Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A (China) 120,200 9,120,222 9,120,222 Health-care providers and services (3.0%) Apollo Hospitals Enterprise, Ltd. (India)(NON) 289,662 12,728,054 Universal Vision Biotechnology Co., Ltd. (Taiwan) 540,000 5,917,702 18,645,756 Hotels, restaurants, and leisure (2.7%) Jubilant Foodworks, Ltd. (India)(NON) 127,363 5,470,363 Yum China Holdings, Inc. -
Update on Equity Stake in Indus Towers
1 September 2020 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Phiroze Jeejeebhoy Bandra - Kurla Complex, Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Dear Sirs, Sub: Update on Bharti Infratel and Indus Towers Merger Ref: Vodafone Idea Limited (the “Company”) (IDEA / 532822) Further to our communication dated 24 June 2020 in relation to the merger of Indus Towers Limited (in which the Company is holding 11.15% equity stake) with Bharti Infratel Limited (“Merger”), please find attached a press release titled “Update on Bharti Infratel and Indus Towers Merger”, being issued to media. The above is for your information and dissemination to the members. Thanking you, Yours truly, For Vodafone Idea Limited Pankaj Kapdeo Company Secretary Encl: As above Vodafone Idea Limited (formerly Idea Cellular Limited) An Aditya Birla Group and Vodafone partnership Birla Centurion, 9th to 12th Floor, Century Mills Compound, Pandurang Budhkar Marg, Worli, Mumbai – 400 030. T: +91 95940 04000F: +91 22 2482 0093 www.vodafoneidea.com Registered Office: Suman Tower, Plot no. 18, Sector 11, Gandhinagar – 382 011, Gujarat. T +91 79 6671 4000 F +91 79 2323 2251 CIN: L32100GJ1996PLC030976 Media Release – September 01, 2020 Update on Bharti Infratel and Indus Towers Merger Vodafone Idea Limited (“VIL”), Vodafone Group Plc (“Vodafone”), Bharti Airtel Limited (“Bharti Airtel”), Indus Towers Limited (“Indus”) and Bharti Infratel Limited (“Infratel”) (collectively referred as “Parties” and individually as “Party”) have agreed to proceed with completion of the merger of Indus and Infratel. VIL has undertaken to sell its 11.15% stake in Indus for cash. -
Investor Presentation – July 2017
Hathway Cable and Datacom Limited Investor Presentation – July 2017 1 Company Overview 2 Company Overview • Hathway Cable & Datacom Limited (Hathway) promoted by Raheja Group, is one Consolidated Revenue* (INR Mn) & of the largest Multi System Operator (MSO) & Cable Broadband service providers in EBITDA Margin (%) India today. 14,000 16.2% 20.0% 13,000 15.0% • The company’s vision is to be a single point access provider, bringing into the home and work place a converged world of information, entertainment and services. 12,000 12.1% 13,682 10.0% 11,000 11,550 5.0% • Hathway is listed on both the BSE and NSE exchanges and has a current market 10,000 0.0% th capitalisation of approximately INR 28 Bn as on 30 June, 2017. FY16 FY17 Broadband Cable Television FY17 Operational - Revenue Break-up • Hathway holds a PAN India ISP license • One of India’s largest Multi System Activation Other and is the first cable television services Operator (MSO), across various regions 6% 2% Cable Subscription provider to offer broadband Internet of the country and transmitting the 34% services same to LCOs or directly to subscribers. • Approximately 4.4 Mn two-way • Extensive network connecting 7.5 Mn Placement broadband homes passed CATV households and 7.2 Mn digital 21% cable subscriber • Total broadband Subscribers – 0.66 Mn • Offers cable television services across Broadband • High-speed cable broadband services 350 cities and major towns across 12 cities (4 metros and 3 mini 37% metros) • 15 in-house channels and 10 Value Added Service (VAS) channels • -
SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI trading as ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP. COTTON GREEN RLY. STN. MUMBAI-400033. MANUFACTURE & MERCHANT INDIAN NATIONAL Used Since :31/01/2001 MUMBAI MEDICINAL PREPARATIONS. 537 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SEPTIGARD 1741718 08/10/2008 INDERJIT SINGH trading as ;INDERJIT SINGH B-104 , SWASTHYA SINGH , NEW DELHI -92 MERCHANTS & MANUFACTUERERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Proposed to be Used DELHI MEDICINAL & PHARMACEUTICAL PREPARATIONS. 538 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 FAIR & BEAUTY 1803779 08/04/2009 GALPHA LABORATORIES LIMITED 221, Kanakia Zillion, E Wing Bandra Kurla Complex Annex LBS Marg & CST Road Junction Kurla West MUMBAI 400070 MANUFACTURERS AND MERCHANTS INDIAN NATIONAL Used Since :15/11/2007 MUMBAI PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES 539 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 O-BAMA 1815900 08/05/2009 KREMOINT PHARMA PVT. LTD. 151/5, SHRI KRISHNA DARSHAN, GARODIA NAGAR, GHATKOPAR (E), BOMBAY-400 077. MANUFACTURERS AND MERCHANTS. A CORPORATE ENTITY INCORPORATED IN INDIA UNDER THE COMPANIES ACT 1956. Address for service in India/Attorney address: KRISLAW CONSULTANTS BUILDING NO.4, C/104, SHANKESHWAR PALMS, BEHIND MODEL SCHOOL, KUMBHARKHANPADA, SUBHASH ROAD, DOMBIVILI(W) 421202 Used Since :02/05/2009 MUMBAI PHARMACETICAL AND MEDICINAL PREPARATIONS. 540 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 AYUSHAKTI D-VYRO 1815928 08/05/2009 SMITA NARAM BUNGALOW NO.31, NEXT TO M. -
09-06-2015 Brochure.Cdr
If IndiGo Ran Your Hospital Ratan Jalan Thanks to Aditya Ghosh, IndiGo's President & Executive Director, I was able to look under the hood and get a peep into this widely acclaimed airline's secret sauce. This article is not aimed at providing a ready-to-implement toolkit of 'things you can do'. It is meant to provoke and facilitate a different way of thinking. If it helps you feel somewhat disturbed, but with a tinge of optimism and possibilities, I would have achieved my objective. I am grateful to Rohini Duvvuri for her painstaking editorial inputs and Rajesh Nambiar for the excellent design. Pictures relating to various facets of IndiGo are used to illustrate the point being made. I am constantly amazed by IndiGo’s trailblazing performance in an industry, which is notorious for its loss making capabilities and has witnessed many corporate casualties. In India alone, the cumulative losses for airlines over the last seven years have crossed ` 65,000 crore. IndiGo, on the other hand, has been the lone profit-maker and has posted six straight years of profits against the backdrop of vicious fare fights. The airline is reportedly expecting to record a net profit of up to ` 2,200 crore in 2014-15 partly on account of Profit in ` crore Frankly, you'll have 1000 nothing to complain 0 2011-12 2012-13 2013-14 2010-11 if IndiGo ran your -1000 hospital. It would -2000 -3000 procure state-of-the-art -4000 -5000 equipment, offer Indigo Spicejet Jet consistently superior low crude oil prices and is targeting for ` 2,500 clinical outcome crore IPO in the next couple of quarters to fund at relatively lower prices expansion. -
Investor Presentation May 2016
Investor Presentation May 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM Safe Harbor Certain statements in this release concerning our future growth prospects are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated in such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others general economic and business conditions in India, our ability to successfully implement our strategy, our research and development efforts, our growth and expansion plans and technological changes, changes in the value of the Rupee and other currencies, changes in the Indian and international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in the foreign exchange control regulations in India. Neither the company, nor its directors and any of the affiliates have any obligation to update or otherwise revise any statements reflecting circumstances arising after this date or to reflect the occurrence of underlying events, even if the underlying assumptions do not come to fruition. 2 Agenda Biocon: Who are we? Highlights • Business Highlights • Financial Highlights Growth Segments • -
Most Market Roundup.Pmd
MOSt Market Roundup 1st March 2019 EQUITY Market Sensex 36063.81 196.37 Nifty 10863.50 71.00 Cash Volumes (INR in Crores) Dealer's Diary Exchange Today Pev. Day Markets bounced back after falling for 3 trading sessions. Nifty climbed BSE (Cash) - 2,082 0.66% or 71 pts to close at 10863. Rally in the global markets and reduced NSE (Cash) 31,263 42,766 geo-political tensions, boosted the market sentiments. Moreover, Feb NSE(Derivatives) 4,05,084 17,00,963 mfg PMI which came at a 14-month high at 54.3, fall in USDINR and 10- Year G-Sec yield, also helped. China (up 1.5%), Nikkei and Hong Index Advance / Decline gained smartly, European markets advanced half to one percent and Group NIFTY 50 BSE 200 US Futures gained over half a percent. China reported impressive Advance 40 158 economy data and reduced trade war tension between US and China, Decline 10 41 boosted the global markets. India VIX slipped nearly 10%. Small-Cap Unchanged 0 2 Index rose close to 3%, followed by PSU Banks, Media, Auto and Metal stocks. Auto monthly sales for February was a mixed bag. Maruti and Top Nifty - 50 Index Gainers Ashok Leyland reported in-line Feb sales while Bajaj Auto announced lower than expected numbers. Escorts announced better-than- Scrip LTP % Change ZEEL 488 4.5 expected Feb sales. Bajaj Auto declined 1% to close at Rs2863, Maruti HINDPETRO 233 4.4 and Escorts gained 1% and 2% respectively. Tata Motors surged 2% to INDUSINDBK 1,517 2.9 close at Rs180 after the news that the company is likely to sell JLR BPCL 347 2.7 stake. -
Financial Performance of Indian Automobile Industry – with Special Reference to Selected Companies
Volume : 5 | Issue : 12 | December-2016 ISSN - 2250-1991 | IF : 5.215 | IC Value : 79.96 Original Research Paper Commerce Financial Performance of Indian Automobile Industry – with Special Reference to Selected Companies Research Scholar, Department of Commerce, Annamalai P.Manokaran University, Annamalai Nagar Tamilnadu Assistant Professor in Commerce, Department of Commerce, Dr.J.Paramasivam Annamalai University,Annamalai Nagar Tamilnadu The study was made with the objective to analyse financial performance of selected automobile companies in India. For this purpose the researcher selected six companies for the study period of ten years from 2005-06 to 2014-15 using Altman’s Z-score model. The study found that financial performance under Altman’s z-score model was good in case of Maruti Suzuki India Ltd., since calculated value of z-score was more than the standard norm during all the years of the study period. The calculated value of z-score of Mahindra and Mahindra Ltd. was more than the standard norm (2.99) during eight years and it was more than the standard norm during eight years in case of Bajaj Auto Ltd. and TVS Motor Company, since their ABSTRACT financial performance was satisfactory. Financial performance of Tata Motors Ltd. and Ashok Leyland Ltd., was good during four years, since their z-score was more than the standard norm during four years and during five years it was at grey zone and in one year it was poor. KEYWORDS financial performance, z-score, working capital, retained earnings and profit Introduction Methodology India is one of the fastest growing economies in the world. -
Hy Sun Missed the Pharma Rally: the Answer Is Hidden in a Bet Many Failed — Speciality Drugs - the Economic Times
12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets News Industry RISE Politics Wealth MF Tech Jobs Opinion NRI Panache ET NOW More Aayush English Edition | E-Paper Tech Consumer Markets Corporate Governance Telecom + OTT Auto + Aviation Pharma Fintech + BFSI Economy Infra Environment Energy Business News › Prime › Pharma › Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Getty Images MARKETS hy Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Dilip Shanghvi, founder and managing director, Sun Pharmaceuticals Synopsis Sun Pharma is the only Indian company to have made some inroads into speciality drugs. What worries investors is high investments and uncertainties over ramp up in revenue. The stock can still see upside because of its current valuations, strong India business, and any positive surprises in US generic business. But it is crucial that its speciality bet pays off. BACK TO TOP https://economictimes.indiatimes.com/prime/pharma-and-healthcare/why-sun-missed-the-pharma-rally-the-answer-is-hidden-in-a-bet-many-failed-spe… 1/11 12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets NeCwasllI nitd uas trbyleRssISiEngP oilniti cdsisWgeuailthse fMoFr tTheceh InJodbisanOpinion NRI Panache ET NOW More pharmaceutical industry. The stocks of pharma companies have been on a tear since the beginning of the Covid-19 crisis. -
IN the BUSINESS of PROGRESS CONTENTS Apollo Tyres in Brief
Annual Report 2019-20 IN THE BUSINESS OF PROGRESS CONTENTS Apollo Tyres in brief 01-03 Apollo Tyres is one of the most trusted Corporate factsheet names in the manufacture and sale of tyres. The Company was founded in 1972 and is 04-13 headquartered in Gurugram, Haryana (India). Leadership and governance 06 Chairman’s message 08 Vice-Chairman’s message 10 Board of Directors Catering to all tyre segments 12 Management Team TRUCK AND BUS LIGHT TRUCK 14-77 Performance and progress 16 Key performance indicators 18 Know our capitals 20 Business model 22 Capital-wise information 36 Progress amidst volatility 38 Progress that is sustainable 40 Progress through people centricity 42 Value created for the stakeholders PASSENGER VEHICLES TWO-WHEELER 78-93 Management Discussion & Analysis 94-170 Statutory Reports 94 Board’s Report 107 Annual Report on CSR 113 Business Responsibility Report 138 Corporate Governance Report OFF-HIGHWAY 171-305 Financial Statements 171 Standalone 233 Consolidated Apollo Tyres’ success as a leading tyre such as: geo-political relations, economic manufacturer is inextricably linked with the growth, industry cyclicality, environmental progress of the people, the businesses we issues, technological innovation, safety and partner and the planet at large. We have consumer attitudes. Our FY20 performance is always persevered to exceed expectations, a reflection of the resulting uncertainties. It set new benchmarks and in some cases, is also a testament to our foundational values shape the future of the industry. and intrinsic strengths that have helped us navigate through these uncertainties. Our marquee brands, Apollo and Vredestein, enjoy premium positions in the commercial As we step into a new decade, replete with and passenger vehicle tyre segments in unexplored opportunities, we are keen on India and Europe, respectively.